Therefore, deciphering the true outcomes or consequences independent of the natural history of a 1 condition is difficult and can be subjective. Continuing the same example above this challenge would 2 involve determining the additional number of nights a patient remained in hospital solely as a result 3 of their medication error as opposed to the natural history of their underlying illness. Taking these 4 factors into account, identifying and calculating each and every additional cost resulting from a 5 medication error remains the main difficulty. 6 7 Other problems relate to the absence of matched patients to enable true comparison of outcomes 8 and, as a result, different outcomes that may also result from the same medication error. This 9 variation leads to sufficient subjectivity in the application of methods for calculating error across 10 care contexts. Finally, some calculations use mainly direct costs, such as the increase in raw cost of a 11 medication to treat a patient following an error [5] , whereas others use specific indirect costs or 12 equate the entire cost of the subsequent care incurred after an error [6] [7] [8] in the calculation for 13 evaluating cost. This implies that some methods may incorrectly estimate the cost of medication 14 errors but more importantly that setting the viewpoint from which the errors are calculated is 15 essential. 16 
17
This variation in methodologies has implications for how the consequent interventions, aimed at 18 reducing medication errors, are evaluated in cost-benefit and effectiveness analyses. Aside all the 19 problems that result from inconsistency in the use of different methods, few approaches are 20 underpinned by methodologies used in health economics. Furthermore, there is also a lack of 21 understanding around how to group different methodologies for calculating medication errors in a 22
given clinical context or for a given type of medication error. The aim of this review is to identify the 23 approaches used for calculating the cost of a medication error across healthcare settings to facilitate 24 future research and evaluation of interventions. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   C  o  n  f  i  d  e  n  t  i  a  l  :  F  o  r  R  e  v  i  e  w  O  n  l  y C  o  n  f  i  d  e  n  t  i  a  l  :  F  o  r  R  e  v  i  e  w  O  n  l  y   6   1 All eligible papers were fully reviewed by two researchers and data was extracted separately into 2 spreadsheets. Any disparity over the interpretation and categorisation of the data was discussed 3 with at least one additional reviewer present and an agreement was reached. 4
The publications were examined to identify factors such as setting, study design and length of study 5 for the purposes of bringing greater context and clarity to the findings. The mode of prescription and 6 the type of medications analysed were identified to find any association with the chosen 7 methodology of calculating the cost of medication errors. It is beyond the scope of this review to 8 analyse the severity of medication errors or their aetiology, therefore it was simply reported 9 whether or not there was any evidence of consideration for these factors within the study designs. 10
11
The definition of medication errors covers a number of potential stages in the process from 12 prescription to administration for an error to occur. Each paper was analysed to see which stages in 13 the Medicines Use Pathway[11] were investigated to detect medication errors. This consists of four 14 distinct stages: 1) prescribing of medication, 2) supply/dispensing of medication, 3) administration of 15 medication and 4) review of the effects of medication. 16
17
From the pilot study, it was evident that some papers examined the impact of medication errors 18 within the context of an intervention aimed at reducing the number or impact of those errors. 19 Therefore, the nature of those interventions, where applicable, was also noted. 20
21
Finally and most importantly, the calculation of costs of medication errors was identified. Particular 22 focus was given to the type of costs which were included in the calculation and whether the cost 23 incurred was directly related to the patient's treatment or otherwise. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   C  o  n  f  i  d  e  n  t  i  a  l  :  F  o  r  R  e  v  i  e  w  O  n  l  y   7   RESULTS  1  2 The literature search heralded 1133 potentially relevant papers. Duplicate papers were filtered 3 within the search command. After applying the exclusion criteria to the publication abstracts, the 48 4 potentially relevant abstracts were singled out. Reading the full articles and excluding those without 5 explicit evidence of calculating cost of a medication error finally left 21 publications for the analysis 6 (See Figure 1) . 7 
Description of Studies 25
As illustrated in Table 1 
Medicines Use Pathway 13
Categorising studies by the medicines use pathway showed that most studies (n=17) focussed on 14 medication errors in the prescribing phase, where the decision is made as to whether a medicine is 15 needed. Fewer studies showed evidence of considering errors occurring at supply/dispensing (n=4), 16 administration (n=8) and in the monitoring of the response to medicines (n=7). Noted was a 17 variation in the terminology used to describe medication errors, with some studies reporting on 18
Adverse Drug Events (ADEs) and other similar phrases. 19 20
Calculation of Medication Errors 21
As illustrated in Table 2 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 There was a wide variety in the factors used to estimate the cost as a result of a medication error 8 (Table 1 -Components of Calculation for ME). The review revealed eight types of factors used for 9 calculating the cost of medication errors (Table 3) . Calculations taking into account ONLY direct costs 17 (81%) Calculations taking into account indirect costs (see Table 1) 3 (14%) Calculations taking into account opportunity costs (see Table 1 ) 1 (5% ) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60 This systematic review was conducted to investigate approaches for calculating the cost of 2 medication errors since there is a need to accurately quantify the impact of interventions for 3 reducing avoidable harm. The findings demonstrate that a standardised approach for exploring the 4 costs of medication errors was lacking, therefore, the development of valid and reliable methods for 5 undertaking calculations are necessary before the impact of interventions for reducing medication 6 errors can be known. 7
8
No previous systematic reviews were found in this area and the primary observation was a general 9 inconsistency in the terminology and methods used by researchers for calculating medication error 10 costs. Furthermore, no studies identified in the review were conducted within a NHS setting, 11 confirming the calculation of true costs following medication errors remains unknown. The cost 12 components within the calculations were also not explicitly defined and varied across studies, so 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In conclusion, there is a wide variation in approaches to calculating the cost of medication errors. 21
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